Home » Tepezza Lawsuit | Tepezza Lawsuits for Hearing Loss & Tinnitus | 2023 Update
Attorney Sean T. Keith has been a personal injury lawyer for 30+ years, a nationally recognized Top 100 Trial Lawyer, and top car accident lawyer & motor vehicle accident lawyer in Arkansas.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Keith Law Group and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Sean T. Keith, you can do so here.
Keith Law Group does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
Tepezza is a medication used to treat Thyroid Eye Disease (TED). Several lawsuits have been filed against the drug’s manufacturer for failing to warn consumers about potentially permanent hearing loss or tinnitus side effects from Tepezza.
If you or a loved one were administered Tepezza to treat Thyroid Eye Disease, and subsequently developed permanent hearing loss, partial hearing loss or tinnitus, you may be eligible to file a Tepezza Lawsuit.
Contact Keith Law Group for a free legal consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.
Our law firm will work hard to seek financial compensation for your damages and losses. We’re not afraid to hold major corporations liable for the damage they cause. Contact us for more information – we promise to keep all confidential or sensitive information safe and secure.
Tepezza (teprotumumab-trbw) is a medication used to treat Thyroid Eye Disease (TED), a rare autoimmune disorder that causes inflammation and swelling in the muscles, nerves, and fatty tissues around the eyes. TED can lead to a variety of symptoms such as double vision, bulging eyes, and difficulty closing the eyes.
Tepezza is administered through intravenous (IV) infusion, typically once every three weeks for a total of eight doses. The infusion takes about 90 minutes to administer.
The medication works by targeting and binding to the insulin growth factor-1 receptor (IGF-1R), which is believed to play a role in the inflammation and tissue damage associated with TED. By binding to this receptor, Tepezza is able to inhibit the activity of IGF-1R and reduce inflammation.
The FDA approved Tepezza in January 2020 as the first treatment of moderate to severe TED in adult patients who are not adequately controlled with topical or systemic medications. The approval was based on data from two clinical trials conducted that showed a significant improvement in the signs and symptoms of TED in patients treated with Tepezza.
Studies have shown that a shocking amount of patients who are administered Tepezza infusions suffered permanent hearing loss, tinnitus, and other hearing problems.
A study published in the National Institutes of Health, National Center for Biotechnology Information found that up to 85% of patients who received Tepezza infusions have experienced hearing loss, tinnitus, and other hearing problems.
Another study conducted by researchers at the Stanford University School of Medicine, published by the Endocrine Society Journal, found that up to 65% of patients included in a study on Tepezza suffered from hearing problems.
Due to the alarming number of patients who have suffered from hearing-related side effects, Tepezza patients, who have experienced hearing loss, have filed lawsuits against the drug’s manufacturer.
Patients who have received Tepezza infusions for thyroid eye disease have suffered hearing loss side effects including the following:
Even though some patients have improvement in symptoms, the side effects do not completely disappear.
Patients may experience the following hearing loss symptoms:
Patients experiencing hearing loss or tinnitus, or other hearing problems may have to undergo surgical treatment, including the following:
As of January 2023, several Tepezza lawsuits are included in a motion filed for consolidation into Multidistrict Litigation (MDL) in the US District Court: Northern District of Illinois.
Multidistrict litigation (MDL) is a legal process in which multiple federal lawsuits that share common questions of fact are consolidated and heard by one judge. This process is typically used in cases involving complex or large-scale litigation, such as mass torts, product liability cases, and securities fraud lawsuits. The primary goal of MDL is to streamline the legal process and reduce duplicative discovery and other pretrial proceedings.
MDL is different from class action lawsuits, which involve a group of plaintiffs who have similar claims against a single defendant. In class action lawsuits, the plaintiffs are typically represented by a single class representative and a lead attorney.
In contrast, each plaintiff in an MDL case retains their own attorney and is considered a separate party to the litigation. Additionally, class action lawsuits typically involve a single judgment that applies to all class members, whereas MDL cases typically result in individual settlements or judgments for each plaintiff.
If you or a loved one has taken Tepezza to treat Thyroid Eye Disease and subsequently experienced hearing-related side effects, you may be eligible to file a Tepezza Lawsuit claim.
If you decide to pursue a Tepezza Lawsuit, our legal team suggests taking certain steps to build a strong case. This includes gathering evidence and determining the damages incurred as a result of the injury. An experienced attorney who specializes in dangerous drug lawsuits can assist you in this process.
To build a strong case, it’s crucial to gather all relevant documentation related to your potential Tepezza lawsuit. This may include:
It’s important to assess the damages incurred as a result of the injury.
Damages can include
An attorney can help you understand the potential damages that can be claimed in a Tepezza Lawsuit.
Our law firm has secured significant amounts of financial compensation for people harmed at no fault of their own.
No matter how big the corporation is, no matter how much they fight accountability, Sean Keith and the team at Keith Law Group will always fight for your rights as a consumer and seek compensation for damages when businesses put customers in danger.
If you or a loved one received Tepezza infusions to treat Thyroid Eye Disease, and subsequently suffered permanent hearing loss or tinnitus, you may be eligible to file a Tepezza Lawsuit.
Contact Keith Law Group for a free case review today, or use the chatbot on this page to see if you qualify to file a Tepezza Hearing Loss Lawsuit instantly.
Lawsuits are being filed against Horizon Therapeutics for failing to properly warn patients about the potential hearing related side effects of taking Tepezza. Contact us if you have questions about filing a Tepezza Lawsuit for hearing issues.
The manufacturer of Tepezza is Horizon Therapeutics. Horizon Therapeutics is bio-pharmaceutical company headquartered in Dublin, Ireland.
The hearing loss side effects of Tepezza potentially include:
According to the FDA webpage on Tepezza, the potential side effects of the drug are as follows:
Some hearing loss or tinnitus side effects from Tepezza have been able to be successfully reversed. Some patients have suffered permanent hearing loss or tinnitus as a result of receiving Tepezza infusions.
As the Tepezza Hearing Loss Lawsuit is in its early stages, we can’t be certain about settlement amounts or compensation for the Tepezza Lawsuit. Visit this page for more updates when Tepezza settlement amount information becomes available.
Our law firm works on a contingency fee basis. This means that if your lawsuit does not end in compensation, you do NOT have to pay for legal representation. Our legal team prides itself on serving the needs of our clients and alleviating the financial burden of being harmed by another person, device, medication, etc.